US Patent 9944720 Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof
Patent 9944720 was granted and assigned to AbbVie Inc. on April, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 4, 2015
0
Date of Patent
April 17, 2018
0
Patent Applicant
Patent Application Number
14845511
0
Patent Inventor Names
Dominic J. Ambrosi
0
Camellia Zamiri
0
Deanna L. Haasch
0
Susan E. Lappe
0
Xianhua Cao
0
Yingchun Li
0
Jijie Gu
0
Jonathan A. Hickson
0
Louie Naumovski
0
Ravi Chari
0
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9944720 Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
